PHIO PHARMACEUTICALS CORP. Interest and Other Income
PHIO PHARMACEUTICALS CORP. (PHIO) reported Interest and Other Income of $6.00 thousand for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-14.
Discontinued › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2014-05-14
- PHIO PHARMACEUTICALS CORP. interest and other income for the quarter ending 2014-03-31 was $6.00K.
- PHIO PHARMACEUTICALS CORP. interest and other income for the quarter ending 2013-12-31 was $10.00K.
- PHIO PHARMACEUTICALS CORP. interest and other income for the quarter ending 2013-09-30 was $10.00K.
- PHIO PHARMACEUTICALS CORP. interest and other income for fiscal 2013 was $24.00K.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month | Interest and Other Income 9 month | Interest and Other Income 12 month |
|---|---|---|---|---|
| 2014-03-31 | $6.00K 10-Q · filed 2014-05-14 | $16.00K derived: sum of 2 quarters · filed 2014-05-14 | $26.00K derived: sum of 3 quarters · filed 2014-05-14 | |
| 2013-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $20.00K derived: sum of 2 quarters · filed 2014-03-28 | $24.00K 10-K · filed 2014-03-28 | |
| 2013-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $14.00K 10-Q · filed 2013-11-14 | ||
| 2013-06-30 | $4.00K 10-Q · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |